Postpartum Depression Treatment Market by Treatment Type (Antidepressant Drugs, Psychotherapy), Distribution (Drug Stores, E-Commerce, Hospital Pharmacies) - Global Forecast 2024-2030

Postpartum Depression Treatment Market by Treatment Type (Antidepressant Drugs, Psychotherapy), Distribution (Drug Stores, E-Commerce, Hospital Pharmacies) - Global Forecast 2024-2030


The Postpartum Depression Treatment Market size was estimated at USD 948.54 million in 2023 and expected to reach USD 1,026.86 million in 2024, at a CAGR 8.74% to reach USD 1,705.58 million by 2030.

Global Postpartum Depression Treatment Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Postpartum Depression Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Postpartum Depression Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Postpartum Depression Treatment Market, highlighting leading vendors and their innovative profiles. These include Accord Healthcare Ltd., Alvogen Group Inc, Anikem Laboratories, AstraZeneca PLC, Bausch Health Companies Inc., Cipla Limited, Eli Lilly and Company, GlaxoSmithKline PLC, H. Lundbeck A/S, Intas Pharmaceuticals Ltd., Lupin Ltd., Mylan N.V., Novartis AG, Pfizer, Inc., Sage Therapeutics, Inc., Sebela Pharmaceuticals, Inc., Shionogi & Company, Limited, Solvay S.A., Sumika Polymer Compounds (EU) Ltd, Sun Pharmaceutical Industries Limited, and Teva Pharmaceuticals Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Postpartum Depression Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Treatment Type
Antidepressant Drugs
Bupropion
Desipramine
Escitalopram
Paroxetine
Sertraline
Tranylcypromine
Trimipramine
Psychotherapy
Cognitive Behavioral Therapy
Interpersonal Psychotherapy
Psychodynamic Psychotherapy
Solution-Focused Brief Psychotherapy
Distribution
Drug Stores
E-Commerce
Hospital Pharmacies
Retail Pharmacies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Postpartum Depression Treatment Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Postpartum Depression Treatment Market?
3. What are the technology trends and regulatory frameworks in the Postpartum Depression Treatment Market?
4. What is the market share of the leading vendors in the Postpartum Depression Treatment Market?
5. Which modes and strategic moves are suitable for entering the Postpartum Depression Treatment Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Postpartum Depression Treatment Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalences of mood disorder associated with pregnancy across the globe
5.1.1.2. Growing demand for antidepressant medication and talk therapies
5.1.1.3. Increasing approvals from regulatory bodies for PPD treatment
5.1.2. Restraints
5.1.2.1. Limited availability of medical professionals
5.1.3. Opportunities
5.1.3.1. Growing availability of telehealth and telemedicine
5.1.3.2. Rising research activities for treatment of Postpartum Depression Treatment (PPD) in emerging markets
5.1.4. Challenges
5.1.4.1. Issues related to product recalls
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Postpartum Depression Treatment Market, by Treatment Type
6.1. Introduction
6.2. Antidepressant Drugs
6.3.1. Bupropion
6.3.2. Desipramine
6.3.3. Escitalopram
6.3.4. Paroxetine
6.3.5. Sertraline
6.3.6. Tranylcypromine
6.3.7. Trimipramine
6.3. Psychotherapy
6.4.1. Cognitive Behavioral Therapy
6.4.2. Interpersonal Psychotherapy
6.4.3. Psychodynamic Psychotherapy
6.4.4. Solution-Focused Brief Psychotherapy
7. Postpartum Depression Treatment Market, by Distribution
7.1. Introduction
7.2. Drug Stores
7.3. E-Commerce
7.4. Hospital Pharmacies
7.5. Retail Pharmacies
8. Americas Postpartum Depression Treatment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Postpartum Depression Treatment Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Postpartum Depression Treatment Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Accord Healthcare Ltd.
12.1.2. Alvogen Group Inc
12.1.3. Anikem Laboratories
12.1.4. AstraZeneca PLC
12.1.5. Bausch Health Companies Inc.
12.1.6. Cipla Limited
12.1.7. Eli Lilly and Company
12.1.8. GlaxoSmithKline PLC
12.1.9. H. Lundbeck A/S
12.1.10. Intas Pharmaceuticals Ltd.
12.1.11. Lupin Ltd.
12.1.12. Mylan N.V.
12.1.13. Novartis AG
12.1.14. Pfizer, Inc.
12.1.15. Sage Therapeutics, Inc.
12.1.16. Sebela Pharmaceuticals, Inc.
12.1.17. Shionogi & Company, Limited
12.1.18. Solvay S.A.
12.1.19. Sumika Polymer Compounds (EU) Ltd
12.1.20. Sun Pharmaceutical Industries Limited
12.1.21. Teva Pharmaceuticals Industries Ltd.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
FIGURE 1. POSTPARTUM DEPRESSION TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. POSTPARTUM DEPRESSION TREATMENT MARKET DYNAMICS
FIGURE 7. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 8. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 10. POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM DEPRESSION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. POSTPARTUM DEPRESSION TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. POSTPARTUM DEPRESSION TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings